Vertex Pharmaceuticals
VRTX
#175
Rank
โ‚ฌ100.30 B
Marketcap
391,21ย โ‚ฌ
Share price
-0.41%
Change (1 day)
-10.55%
Change (1 year)

Earnings for Vertex Pharmaceuticals (VRTX)

Earnings in 2025 (TTM): โ‚ฌ3.97 Billion

According to Vertex Pharmaceuticals's latest financial reports the company's current earnings are โ‚ฌ11.72 Billion. In 2024 the company made an earning of โ‚ฌ0.23 Billion a decrease over its 2023 earnings that were of โ‚ฌ3.79 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Vertex Pharmaceuticals from 1990 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) โ‚ฌ3.97 B1557.71%
2024 โ‚ฌ0.23 B-93.69%
2023 โ‚ฌ3.79 B3.19%
2022 โ‚ฌ3.68 B53.56%
2021 โ‚ฌ2.39 B-12.06%
2020 โ‚ฌ2.72 B118.45%
2019 โ‚ฌ1.24 B120.64%
2018 โ‚ฌ0.56 B1473.64%
2017 โ‚ฌ35.95 M197.6%
2016 โ‚ฌ12.08 M-102.97%
2015 -โ‚ฌ0.41 Billion-28.46%
2014 -โ‚ฌ0.57 Billion-51.5%
2013 -โ‚ฌ1.18 Billion-30584.68%
2012 โ‚ฌ3.84 M-95.47%
2011 โ‚ฌ84.94 M
2009 -โ‚ฌ0.51 Billion
2007 -โ‚ฌ0.36 Billion83.1%
2006 -โ‚ฌ0.2 Billion59.02%
2005 -โ‚ฌ0.13 Billion3.28%
2004 -โ‚ฌ0.12 Billion-38.16%
2003 -โ‚ฌ0.2 Billion
2000 -โ‚ฌ32.68 Million-20.38%
1999 -โ‚ฌ41.04 Million31.62%
1998 -โ‚ฌ31.18 Million91.05%
1997 -โ‚ฌ16.32 Million-36.24%
1996 -โ‚ฌ25.6 Million12.45%
1995 -โ‚ฌ22.77 Million27.4%
1994 -โ‚ฌ17.87 Million-1833.33%
1993 โ‚ฌ1.03 M-112.12%
1992 -โ‚ฌ8.51 Million175%
1991 -โ‚ฌ3.1 Million-12.2%
1990 -โ‚ฌ3.53 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Gilead Sciences
GILD
โ‚ฌ8.49 B 121.58%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
โ‚ฌ1.42 B-62.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
โ‚ฌ19.83 B 417.54%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚ฌ6.89 B 80.05%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
โ‚ฌ27.82 B 626.12%๐Ÿ‡บ๐Ÿ‡ธ USA
Enanta Pharmaceuticals
ENTA
-โ‚ฌ74.04 Million-101.93%๐Ÿ‡บ๐Ÿ‡ธ USA